ZLCS News Alert Zalicus Inc (ZLCS) 1.18 12/16/2014 21:33:35

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Zalicus Inc (ZLCS) 1.18 $ZLCS

EPIRUS Biopharmaceuticals Reports Third Quarter Results and Provides Corporate Update
Business Wire - Mon Nov 10, 3:30PM CST
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ:EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today provided a corporate update and reported financial results for the third quarter ended September 30, 2014.
ZLCS: 1.18 (+0.03), EPRS: 4.79 (-0.04)

Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. to Serve on EPIRUS Board of Directors
Business Wire - Tue Jul 15, 10:49AM CDT
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, announced that Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. will serve on its board of directors. The board, which was reconstituted today following the company's merger with Zalicus Inc. (Zalicus, NASDAQ: ZLCS), also includes Amit Munshi, Geoffrey Duyk, Scott Rocklage, J. Kevin Buchi and Daotian Fu.
CRME: 8.95 (-0.01), TRVN: 4.50 (+0.19), AVNR: 16.91 (-0.04), ZLCS: 1.18 (+0.03), IRWD: 13.80 (+0.10), CBST: 96.73 (+0.42), EPRS: 4.79 (-0.04)

EPIRUS and Zalicus Complete Merger - Combined Company Will Trade as EPIRUS Biopharmaceuticals, Inc. (NASDAQ: EPRS)
Business Wire - Tue Jul 15, 10:47AM CDT
--EPIRUS reconstitutes Board of Directors to include Mark H.N. Corrigan, M.D., Julie H. McHugh, William Hunter, M.D., Amit Munshi, Geoffrey Duyk, Scott Rocklage, J. Kevin Buchi and Daotian Fu
ZLCS: 1.18 (+0.03), EPRS: 4.79 (-0.04)

Zalicus and Epirus Agree Zalicus Stockholders to Own 19% of Combined Company Post-Merger
Business Wire - Wed Jun 25, 7:30AM CDT
Zalicus Inc. (Nasdaq Capital Market: ZLCS) ("Zalicus" , and Epirus Biopharmaceuticals, Inc. ("Epirus" agreed today that Zalicus stockholders will own 19% of the combined company post-merger. Pursuant to its merger agreement with Epirus Biopharmaceuticals, Inc., the percentage of the combined company that Zalicus stockholders will own as of the closing of the merger was subject to adjustment at the closing based on the level of Zalicus' net cash as of a determination date prior to the closing. Based on Zalicus' current level of net cash, both companies have agreed that stockholders of Zalicus will own approximately 19% of the combined company and current Epirus equityholders will own approximately 81% of the Company following the merger.
ZLCS: 1.18 (+0.03)

Anabios Licenses Sodium Channel Blocking Pain Therapeutic Portfolio from Zalicus
PRWeb - Thu Jun 19, 3:16AM CDT
AnaBios Corporation announced today the licensing of a portfolio of novel preclinical, sodium channel blocking pain therapeutics from Zalicus Inc. The agreement is aimed at accelerating the successful development of new selective sodium channel blockers by employing AnaBios' proprietary Phase X™ technology. Under the terms of the agreement, AnaBios acquires an exclusive license for all development and commercialization rights related to Zalicus' Nav1.7 portfolio of compounds, having a projected commercial market of at least $1.5B annually. In addition, Zalicus will be eligible for future clinical and regulatory milestone payments from AnaBios and the two companies will share in royalty payments based upon any potential future product sales.
ZLCS: 1.18 (+0.03)

Zalicus Licenses Sodium Channel Pain Modulation Program
Business Wire - Wed Jun 18, 7:30AM CDT
Zalicus Inc. (Nasdaq Capital Market: ZLCS), a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain, today announced that it has licensed its Sodium Channel Modulator program, including intellectual property and related pipeline assets, to AnaBios Corporation in exchange for clinical milestone payments and royalties on potential future sales. Under the terms of the agreement Zalicus will be eligible to receive up to $17.2 million in clinical and regulatory milestone payments and up to 12% of net sales on any future products resulting from this license.
ZLCS: 1.18 (+0.03)

Sales, Clinical Hold Removal, Trial Initiations, and Committee Recommendations - Analyst Notes on Geron, Zalicus, Northwest Biotherapeutics, Progenics and TG Therapeutics
PR Newswire - Tue Jun 17, 4:30AM CDT
Today, Analysts Review released its analysts' notes regarding Geron Corporation (NASDAQ: GERN), Zalicus Inc. (NASDAQ: ZLCS), Northwest Biotherapeutics, Inc. (NASDAQ: NWBO), Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) and TG Therapeutics, Inc. (NASDAQ: TGTX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3775-100free.
PGNX: 6.99 (-0.01), NWBO: 4.94 (-0.02), ZLCS: 1.18 (+0.03), GERN: 3.04 (+0.06), TGTX: 16.78 (-0.22)

Short Squeeze Starting in Zalicus (ZLCS) According to WealthMakers.com Report
M2 - Fri Jun 13, 6:54AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a research report on Zalicus (NASDAQ: ZLCS). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $1.49 and the projected fundamental valuation of $6.60.
ZLCS: 1.18 (+0.03)

Why Zalicus (ZLCS) Stock Is Surging Today
at The Street - Thu Jun 12, 10:10AM CDT
Zalicus (ZLCS) surged Thursday after Epirus Switzerland announced clinical data from a Phase 3 study of BOW015, a biosimilar infliximab, in patients with active rheumatoid arthritis.
ZLCS: 1.18 (+0.03)

Canadian Forex Review: C$ Strengthens
Commodity News Service Canada - Commodity News Service Canada, Inc. - Wed Feb 12, 3:44PM CST
The Canadian dollar strengthened against the US dollar on Wednesday amid positive Chinese trade data, analysts said.
RNN: 0.71 (unch), ZLCS: 1.18 (+0.03), CHYR: 2.80 (unch), CATM: 36.64 (-0.14), UAL: 61.63 (-2.41)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 131

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
EUBG Faces Tough Third Quarter Amid Challenges

Updated Category News Views 187

What's Happening with EUBG? Entrepreneur Universe Bright Group, better known in the markets as EUBG, is navigating some choppy waters if their recent financial numbers are anything to go by. You'd think companies boasting a digital-focused strategy would be printing money in today's tech-driven world, but EUBG's third quarter of 2026 has a different story to tell. The...

Continue Reading
Webull Faces FINRA Fine and Legal Battle Ahead

Updated Category News Views 187

Webull's Compliance Headache Webull’s been knocked around again. This time, the Financial Industry Regulatory Authority (FINRA) slapped it with a hefty $4.2 million fine. Talk about a hit to the wallet! It all boils down to them failing to roll out some basic anti-money laundering (AML) and other crucial compliance programs. This is no small oversight, and it's got...

Continue Reading
Sharon Stuart's Quest for Her Hidden Origins

Updated Category News Views 123

Delving Into Identity: A Personal Odyssey In a world where everyone seems to be searching for something, Sharon Stuart's quest is etched with the raw need to uncover her real origins. Abandoned as a newborn in the gritty streets of Oakland, she grew up grappling with looming questions about what made her who she is. Her journey is captured in her memoir, "Existing Without...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 100

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
MacKenzie-Childs Grinds Into Spotlight with Oprah's Nod

Updated Category News Views 69

Oprah's Golden Touch: 30 Years Strong Every year, there are a few select spots that brands covet like a hawk on a rabbit hunt. Getting on Oprah’s 'Favorite Things' list is surely one of them. Just like that, the MacKenzie-Childs Electric Salt and Pepper Grinder Set has muscled its way into the 2026 selection. Spare me the bells and whistles; this is like hitting the...

Continue Reading
SiteOne Joins S&P SmallCap 600 Amid KKR's Integer Buyout

Updated Category News Views 122

Changes on the SmallCap Horizon Starting off, SiteOne Landscape Supply (NYSE: SITE) is hopping onto the S&P SmallCap 600 bandwagon. This shift activates just as the market revs up on November 19, 2026. SiteOne is stepping in as Integer Holdings Corp. (NYSE: ITGR) makes its grand exit, a move prompted by a significant acquisition by KKR & Co. Inc. (NYSE: KKR). KKR’s...

Continue Reading
XKIG Bolsters Northwest with Jensen's Acquisition

Updated Category News Views 44

Stepping Up the Game in the Pacific Northwest Well, here we see another classic example of a shrewd move in the infrastructure sector. XKIG, a name known to those who keep an eye on critical infrastructure services for utilities, has decided to widen its footprint with a strategic grab of Jensen's Tree Service, Inc. They’re setting up shop even deeper in the Pacific...

Continue Reading
Go NYC's Perks: Making Commutes Rewarding in NYC

Updated Category News Views 127

Go NYC's Perks: Turning Commutes into Gains I’ve seen a lot of schemes aimed at getting folks to change their travel habits, but this one from Go NYC caught my attention. These guys are trying to squeeze some extra value out of the daily grind for anyone hoofing it across the Big Apple. A new rewards program named Perks kicks off, offering all kinds of discounts and...

Continue Reading
Texxon Faces Revenue Slide Amid Strategic Shifts

Updated Category News Views 44

Texxon's Strategic Transitions and Financial Headaches Texxon Holding Limited (NASDAQ:NPT) just laid their cards on the table, unveiling a mixed bag in their fiscal year 2026 results. As the world's chemical and plastics scene faces winds of change, Texxon buckled down and tried to steer the ship clear from the rocks. It's a balancing act juggling market headwinds, a new...

Continue Reading

Top 5 Most Recently Viewed Articles

New Research Grants Support Diet Impact on Health Outcomes

Updated Category News Views 85

New Research Grants Empower Understanding of Diet and Health Healthcare technology company Komodo Health has recently announced the recipients of its 2024 Diet-Related Health (DRH) grants. These grants are aimed at advancing research that explores the pivotal influence of diet on various health outcomes. Funded by the Robert Wood Johnson Foundation (RWJF), the DRH program...

Continue Reading
Innovative Cardiology Care with Dr. Butkevich's Hybrid Choice™

Updated Category News Views 118

Dr. Alexander Butkevich Introduces Hybrid Choice™ Concierge Program Patients in the Houston area can now access a unique cardiology service from Dr. Alexander Butkevich, MD, thanks to Concierge Choice Physicians. This innovative program provides enhanced connectivity and personalized care adjustments, catering to the evolving needs of patients. The Unique Benefits of...

Continue Reading
Revolutionizing Cryptocurrency with ALR MINER's AI Cloud Service

Updated Category News Views 274

Revolutionizing Cryptocurrency Mining ALR MINER has emerged as a pioneering force in the cryptocurrency world by launching a groundbreaking zero-cost AI cloud mining platform. This innovative approach gives users the opportunity to earn cryptocurrencies like Bitcoin, Ethereum, Dogecoin, and Ripple without any upfront costs, reshaping the way mining is perceived and...

Continue Reading
Instacart Positioned Well Amid Competition with Major Rivals

Updated Category News Views 279

Instacart's Competitive Landscape Instacart (NASDAQ:CART) has made a notable mark in the online grocery delivery sector, and analysts from Goldman Sachs believe its stock is already reflecting the ongoing competition. Despite challenges from giants like Amazon, Uber, and DoorDash, there are reasons to maintain a bullish outlook on Instacart. Supporting Recommendation from...

Continue Reading
Daily Mango Benefits: Heart Health Insights for Women

Updated Category News Views 238

Exploring Mango's Heart Health Benefits Mangos have long been celebrated for their vibrant flavor and nutritional perks. Recent studies now emerge, shedding light on the potential heart and metabolic health benefits of daily mango consumption, particularly for postmenopausal women. This demographic faces unique challenges as they navigate changes in their bodies and...

Continue Reading